nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—Procainamide—Sunitinib—kidney cancer	0.334	1	CrCrCtD
Lidocaine—ABCB1—kidney cancer	0.0741	1	CbGaD
Lidocaine—EGFR—Erlotinib—kidney cancer	0.0704	0.17	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0229	0.0554	CbGbCtD
Lidocaine—CYP3A7—Temsirolimus—kidney cancer	0.0229	0.0554	CbGbCtD
Lidocaine—SLC22A5—Dactinomycin—kidney cancer	0.0212	0.0512	CbGbCtD
Lidocaine—CYP3A5—Temsirolimus—kidney cancer	0.0172	0.0416	CbGbCtD
Lidocaine—ABCB1—Temsirolimus—kidney cancer	0.0112	0.0271	CbGbCtD
Lidocaine—CYP2D6—Temsirolimus—kidney cancer	0.0105	0.0255	CbGbCtD
Lidocaine—CYP3A4—Everolimus—kidney cancer	0.00992	0.024	CbGbCtD
Lidocaine—CYP2C8—Pazopanib—kidney cancer	0.00868	0.021	CbGbCtD
Lidocaine—CYP3A7—Paclitaxel—kidney cancer	0.00786	0.019	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00786	0.019	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00698	0.0169	CbGbCtD
Lidocaine—CYP3A7—Sorafenib—kidney cancer	0.00698	0.0169	CbGbCtD
Lidocaine—CYP3A7—Vincristine—kidney cancer	0.00678	0.0164	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00678	0.0164	CbGbCtD
Lidocaine—CYP1A2—Pazopanib—kidney cancer	0.00672	0.0163	CbGbCtD
Lidocaine—CYP3A4—Temsirolimus—kidney cancer	0.0067	0.0162	CbGbCtD
Lidocaine—CYP2B6—Sorafenib—kidney cancer	0.00665	0.0161	CbGbCtD
Lidocaine—CYP3A5—Erlotinib—kidney cancer	0.00644	0.0156	CbGbCtD
Lidocaine—CYP2C9—Capecitabine—kidney cancer	0.00631	0.0153	CbGbCtD
Lidocaine—CYP2C8—Erlotinib—kidney cancer	0.00619	0.015	CbGbCtD
Lidocaine—CYP3A5—Paclitaxel—kidney cancer	0.00589	0.0143	CbGbCtD
Lidocaine—ABCB1—Pazopanib—kidney cancer	0.00587	0.0142	CbGbCtD
Lidocaine—CYP2C8—Paclitaxel—kidney cancer	0.00567	0.0137	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00566	0.0137	CbGbCtD
Lidocaine—CYP3A7—Sunitinib—kidney cancer	0.00566	0.0137	CbGbCtD
Lidocaine—CYP2D6—Pazopanib—kidney cancer	0.00553	0.0134	CbGbCtD
Lidocaine—ABCB1—Dactinomycin—kidney cancer	0.00537	0.013	CbGbCtD
Lidocaine—CYP3A5—Sorafenib—kidney cancer	0.00524	0.0127	CbGbCtD
Lidocaine—CYP3A5—Vincristine—kidney cancer	0.00508	0.0123	CbGbCtD
Lidocaine—CYP2C8—Sorafenib—kidney cancer	0.00503	0.0122	CbGbCtD
Lidocaine—CYP1A2—Erlotinib—kidney cancer	0.00479	0.0116	CbGbCtD
Lidocaine—ABCB1—Gemcitabine—kidney cancer	0.00425	0.0103	CbGbCtD
Lidocaine—CYP3A5—Sunitinib—kidney cancer	0.00424	0.0103	CbGbCtD
Lidocaine—ABCB1—Erlotinib—kidney cancer	0.00419	0.0101	CbGbCtD
Lidocaine—CYP2B6—Doxorubicin—kidney cancer	0.00403	0.00976	CbGbCtD
Lidocaine—CYP2C9—Paclitaxel—kidney cancer	0.00395	0.00956	CbGbCtD
Lidocaine—CYP2D6—Erlotinib—kidney cancer	0.00395	0.00955	CbGbCtD
Lidocaine—CYP1A2—Sorafenib—kidney cancer	0.0039	0.00943	CbGbCtD
Lidocaine—ABCB1—Paclitaxel—kidney cancer	0.00384	0.00928	CbGbCtD
Lidocaine—CYP3A4—Pazopanib—kidney cancer	0.00352	0.00851	CbGbCtD
Lidocaine—CYP2C9—Sorafenib—kidney cancer	0.00351	0.0085	CbGbCtD
Lidocaine—ABCB1—Sorafenib—kidney cancer	0.00341	0.00824	CbGbCtD
Lidocaine—ABCB1—Vinblastine—kidney cancer	0.00336	0.00814	CbGbCtD
Lidocaine—ABCB1—Vincristine—kidney cancer	0.00331	0.008	CbGbCtD
Lidocaine—CYP2D6—Sorafenib—kidney cancer	0.00321	0.00777	CbGbCtD
Lidocaine—CYP2D6—Vinblastine—kidney cancer	0.00317	0.00767	CbGbCtD
Lidocaine—ABCB1—Sunitinib—kidney cancer	0.00276	0.00668	CbGbCtD
Lidocaine—CYP3A4—Erlotinib—kidney cancer	0.00251	0.00608	CbGbCtD
Lidocaine—CYP3A4—Paclitaxel—kidney cancer	0.0023	0.00556	CbGbCtD
Lidocaine—ABCB1—Doxorubicin—kidney cancer	0.00207	0.005	CbGbCtD
Lidocaine—CYP3A4—Sorafenib—kidney cancer	0.00204	0.00494	CbGbCtD
Lidocaine—CYP3A4—Vinblastine—kidney cancer	0.00202	0.00488	CbGbCtD
Lidocaine—CYP3A4—Vincristine—kidney cancer	0.00198	0.0048	CbGbCtD
Lidocaine—CYP2D6—Doxorubicin—kidney cancer	0.00195	0.00471	CbGbCtD
Lidocaine—CYP3A4—Sunitinib—kidney cancer	0.00165	0.004	CbGbCtD
Lidocaine—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00164	1	CbGdCrCtD
Lidocaine—CYP3A4—Doxorubicin—kidney cancer	0.00124	0.003	CbGbCtD
Lidocaine—CYP1A2—urine—kidney cancer	0.0011	0.0686	CbGeAlD
Lidocaine—CYP2C9—urine—kidney cancer	0.00104	0.0652	CbGeAlD
Lidocaine—SCN9A—nephron tubule—kidney cancer	0.000809	0.0507	CbGeAlD
Lidocaine—CYP3A4—urine—kidney cancer	0.000793	0.0497	CbGeAlD
Lidocaine—CYP2D6—urine—kidney cancer	0.00078	0.0489	CbGeAlD
Lidocaine—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000687	0.0431	CbGeAlD
Lidocaine—SCN4A—renal system—kidney cancer	0.000656	0.0411	CbGeAlD
Lidocaine—SCN4A—kidney—kidney cancer	0.000635	0.0398	CbGeAlD
Lidocaine—SCN10A—nephron tubule—kidney cancer	0.000616	0.0386	CbGeAlD
Lidocaine—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000588	0.0368	CbGeAlD
Lidocaine—SCN2A—cortex of kidney—kidney cancer	0.000547	0.0343	CbGeAlD
Lidocaine—SCN3A—renal system—kidney cancer	0.000511	0.032	CbGeAlD
Lidocaine—SCN3A—kidney—kidney cancer	0.000494	0.0309	CbGeAlD
Lidocaine—SCN3A—cortex of kidney—kidney cancer	0.000481	0.0301	CbGeAlD
Lidocaine—Chloroprocaine—BCHE—kidney cancer	0.000456	0.428	CrCbGaD
Lidocaine—SCN5A—cardiac atrium—kidney cancer	0.000456	0.0286	CbGeAlD
Lidocaine—Procainamide—ACHE—kidney cancer	0.000383	0.36	CrCbGaD
Lidocaine—SLC22A5—nephron tubule—kidney cancer	0.000325	0.0204	CbGeAlD
Lidocaine—SLC22A5—renal system—kidney cancer	0.000296	0.0185	CbGeAlD
Lidocaine—CYP2C8—renal system—kidney cancer	0.000286	0.0179	CbGeAlD
Lidocaine—SLC22A5—kidney—kidney cancer	0.000286	0.0179	CbGeAlD
Lidocaine—CYP3A5—nephron tubule—kidney cancer	0.000284	0.0178	CbGeAlD
Lidocaine—CYP2B6—nephron tubule—kidney cancer	0.000283	0.0177	CbGeAlD
Lidocaine—SLC22A5—cortex of kidney—kidney cancer	0.000279	0.0175	CbGeAlD
Lidocaine—CYP2C8—kidney—kidney cancer	0.000277	0.0174	CbGeAlD
Lidocaine—CYP1A2—renal system—kidney cancer	0.000268	0.0168	CbGeAlD
Lidocaine—SLC22A5—cardiac atrium—kidney cancer	0.000265	0.0166	CbGeAlD
Lidocaine—CYP3A5—renal system—kidney cancer	0.000259	0.0162	CbGeAlD
Lidocaine—CYP2B6—renal system—kidney cancer	0.000257	0.0161	CbGeAlD
Lidocaine—CYP3A5—kidney—kidney cancer	0.00025	0.0157	CbGeAlD
Lidocaine—CYP2B6—kidney—kidney cancer	0.000248	0.0156	CbGeAlD
Lidocaine—CYP3A5—cortex of kidney—kidney cancer	0.000243	0.0153	CbGeAlD
Lidocaine—CYP2B6—gonad—kidney cancer	0.00023	0.0144	CbGeAlD
Lidocaine—Procainamide—BCHE—kidney cancer	0.000225	0.212	CrCbGaD
Lidocaine—CYP3A4—renal system—kidney cancer	0.000194	0.0122	CbGeAlD
Lidocaine—CYP2D6—renal system—kidney cancer	0.000191	0.012	CbGeAlD
Lidocaine—CYP3A4—kidney—kidney cancer	0.000188	0.0118	CbGeAlD
Lidocaine—CYP2D6—kidney—kidney cancer	0.000185	0.0116	CbGeAlD
Lidocaine—ABCB1—nephron tubule—kidney cancer	0.000151	0.00947	CbGeAlD
Lidocaine—ABCB1—renal system—kidney cancer	0.000137	0.00861	CbGeAlD
Lidocaine—ABCB1—kidney—kidney cancer	0.000133	0.00832	CbGeAlD
Lidocaine—ABCB1—cortex of kidney—kidney cancer	0.000129	0.0081	CbGeAlD
Lidocaine—ABCB1—gonad—kidney cancer	0.000123	0.00772	CbGeAlD
Lidocaine—Nausea—Temsirolimus—kidney cancer	0.000109	0.0012	CcSEcCtD
Lidocaine—Dermatitis—Pazopanib—kidney cancer	0.000109	0.0012	CcSEcCtD
Lidocaine—Bronchospasm—Capecitabine—kidney cancer	0.000109	0.0012	CcSEcCtD
Lidocaine—Agitation—Vincristine—kidney cancer	0.000109	0.0012	CcSEcCtD
Lidocaine—Back pain—Gemcitabine—kidney cancer	0.000108	0.0012	CcSEcCtD
Lidocaine—Skin exfoliation—Doxorubicin—kidney cancer	0.000108	0.0012	CcSEcCtD
Lidocaine—Haemoglobin—Paclitaxel—kidney cancer	0.000108	0.0012	CcSEcCtD
Lidocaine—Headache—Pazopanib—kidney cancer	0.000108	0.0012	CcSEcCtD
Lidocaine—Rhinitis—Paclitaxel—kidney cancer	0.000108	0.00119	CcSEcCtD
Lidocaine—Oedema—Dactinomycin—kidney cancer	0.000108	0.00119	CcSEcCtD
Lidocaine—Haemorrhage—Paclitaxel—kidney cancer	0.000108	0.00119	CcSEcCtD
Lidocaine—Sweating increased—Capecitabine—kidney cancer	0.000108	0.00119	CcSEcCtD
Lidocaine—Hypoaesthesia—Paclitaxel—kidney cancer	0.000107	0.00119	CcSEcCtD
Lidocaine—Neuropathy—Doxorubicin—kidney cancer	0.000107	0.00118	CcSEcCtD
Lidocaine—Dyspnoea—Sorafenib—kidney cancer	0.000106	0.00117	CcSEcCtD
Lidocaine—Visual impairment—Paclitaxel—kidney cancer	0.000104	0.00115	CcSEcCtD
Lidocaine—Coma—Doxorubicin—kidney cancer	0.000104	0.00115	CcSEcCtD
Lidocaine—Nausea—Pazopanib—kidney cancer	0.000103	0.00113	CcSEcCtD
Lidocaine—Paraesthesia—Sunitinib—kidney cancer	0.000102	0.00113	CcSEcCtD
Lidocaine—Convulsion—Vincristine—kidney cancer	0.000102	0.00113	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000102	0.00113	CcSEcCtD
Lidocaine—Hypertension—Vincristine—kidney cancer	0.000102	0.00113	CcSEcCtD
Lidocaine—Dyspnoea—Sunitinib—kidney cancer	0.000102	0.00112	CcSEcCtD
Lidocaine—Pain—Sorafenib—kidney cancer	0.000101	0.00112	CcSEcCtD
Lidocaine—Hypersensitivity—Vinblastine—kidney cancer	0.000101	0.00112	CcSEcCtD
Lidocaine—Eye disorder—Paclitaxel—kidney cancer	0.000101	0.00111	CcSEcCtD
Lidocaine—Hypersensitivity—Everolimus—kidney cancer	0.000101	0.00111	CcSEcCtD
Lidocaine—Tinnitus—Paclitaxel—kidney cancer	0.000101	0.00111	CcSEcCtD
Lidocaine—Cardiac disorder—Paclitaxel—kidney cancer	0.0001	0.00111	CcSEcCtD
Lidocaine—Flushing—Paclitaxel—kidney cancer	0.0001	0.00111	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Sunitinib—kidney cancer	9.85e-05	0.00109	CcSEcCtD
Lidocaine—Asthenia—Vinblastine—kidney cancer	9.84e-05	0.00109	CcSEcCtD
Lidocaine—Asthenia—Everolimus—kidney cancer	9.8e-05	0.00108	CcSEcCtD
Lidocaine—Angiopathy—Paclitaxel—kidney cancer	9.79e-05	0.00108	CcSEcCtD
Lidocaine—Pain—Sunitinib—kidney cancer	9.75e-05	0.00108	CcSEcCtD
Lidocaine—Immune system disorder—Paclitaxel—kidney cancer	9.74e-05	0.00108	CcSEcCtD
Lidocaine—Hypertension—Gemcitabine—kidney cancer	9.68e-05	0.00107	CcSEcCtD
Lidocaine—Chills—Paclitaxel—kidney cancer	9.68e-05	0.00107	CcSEcCtD
Lidocaine—Neuropathy peripheral—Capecitabine—kidney cancer	9.67e-05	0.00107	CcSEcCtD
Lidocaine—Anaphylactic shock—Vincristine—kidney cancer	9.65e-05	0.00107	CcSEcCtD
Lidocaine—Oedema—Vincristine—kidney cancer	9.65e-05	0.00107	CcSEcCtD
Lidocaine—Stomatitis—Capecitabine—kidney cancer	9.61e-05	0.00106	CcSEcCtD
Lidocaine—Chest pain—Gemcitabine—kidney cancer	9.55e-05	0.00105	CcSEcCtD
Lidocaine—Nervous system disorder—Vincristine—kidney cancer	9.46e-05	0.00104	CcSEcCtD
Lidocaine—Asthenia—Erlotinib—kidney cancer	9.45e-05	0.00104	CcSEcCtD
Lidocaine—Urticaria—Sorafenib—kidney cancer	9.42e-05	0.00104	CcSEcCtD
Lidocaine—Erythema—Paclitaxel—kidney cancer	9.39e-05	0.00104	CcSEcCtD
Lidocaine—Hyperhidrosis—Vincristine—kidney cancer	9.33e-05	0.00103	CcSEcCtD
Lidocaine—Pain—Dactinomycin—kidney cancer	9.23e-05	0.00102	CcSEcCtD
Lidocaine—Tension—Paclitaxel—kidney cancer	9.21e-05	0.00102	CcSEcCtD
Lidocaine—Dysgeusia—Paclitaxel—kidney cancer	9.19e-05	0.00102	CcSEcCtD
Lidocaine—Anaphylactic shock—Gemcitabine—kidney cancer	9.15e-05	0.00101	CcSEcCtD
Lidocaine—Oedema—Gemcitabine—kidney cancer	9.15e-05	0.00101	CcSEcCtD
Lidocaine—Nervousness—Paclitaxel—kidney cancer	9.12e-05	0.00101	CcSEcCtD
Lidocaine—Back pain—Paclitaxel—kidney cancer	9.08e-05	0.001	CcSEcCtD
Lidocaine—Dizziness—Vinblastine—kidney cancer	9.07e-05	0.001	CcSEcCtD
Lidocaine—Dizziness—Everolimus—kidney cancer	9.03e-05	0.000997	CcSEcCtD
Lidocaine—Hypotension—Vincristine—kidney cancer	9.02e-05	0.000996	CcSEcCtD
Lidocaine—Bradycardia—Capecitabine—kidney cancer	9.01e-05	0.000995	CcSEcCtD
Lidocaine—Nervous system disorder—Gemcitabine—kidney cancer	8.98e-05	0.000991	CcSEcCtD
Lidocaine—Feeling abnormal—Dactinomycin—kidney cancer	8.9e-05	0.000983	CcSEcCtD
Lidocaine—Haemoglobin—Capecitabine—kidney cancer	8.9e-05	0.000983	CcSEcCtD
Lidocaine—Rhinitis—Capecitabine—kidney cancer	8.87e-05	0.00098	CcSEcCtD
Lidocaine—Haemorrhage—Capecitabine—kidney cancer	8.85e-05	0.000978	CcSEcCtD
Lidocaine—Vision blurred—Paclitaxel—kidney cancer	8.85e-05	0.000977	CcSEcCtD
Lidocaine—Hyperhidrosis—Gemcitabine—kidney cancer	8.85e-05	0.000977	CcSEcCtD
Lidocaine—Hypoaesthesia—Capecitabine—kidney cancer	8.81e-05	0.000973	CcSEcCtD
Lidocaine—Tremor—Paclitaxel—kidney cancer	8.8e-05	0.000972	CcSEcCtD
Lidocaine—Hypersensitivity—Sorafenib—kidney cancer	8.73e-05	0.000965	CcSEcCtD
Lidocaine—Vomiting—Vinblastine—kidney cancer	8.72e-05	0.000963	CcSEcCtD
Lidocaine—Dizziness—Erlotinib—kidney cancer	8.71e-05	0.000962	CcSEcCtD
Lidocaine—Vomiting—Everolimus—kidney cancer	8.68e-05	0.000959	CcSEcCtD
Lidocaine—Paraesthesia—Vincristine—kidney cancer	8.66e-05	0.000957	CcSEcCtD
Lidocaine—Dermatitis bullous—Doxorubicin—kidney cancer	8.63e-05	0.000953	CcSEcCtD
Lidocaine—Agitation—Paclitaxel—kidney cancer	8.63e-05	0.000953	CcSEcCtD
Lidocaine—Rash—Everolimus—kidney cancer	8.61e-05	0.000951	CcSEcCtD
Lidocaine—Dermatitis—Everolimus—kidney cancer	8.6e-05	0.00095	CcSEcCtD
Lidocaine—Headache—Vinblastine—kidney cancer	8.59e-05	0.000949	CcSEcCtD
Lidocaine—Angioedema—Paclitaxel—kidney cancer	8.58e-05	0.000948	CcSEcCtD
Lidocaine—Headache—Everolimus—kidney cancer	8.56e-05	0.000945	CcSEcCtD
Lidocaine—Hypotension—Gemcitabine—kidney cancer	8.55e-05	0.000945	CcSEcCtD
Lidocaine—Visual impairment—Capecitabine—kidney cancer	8.53e-05	0.000942	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Doxorubicin—kidney cancer	8.52e-05	0.000941	CcSEcCtD
Lidocaine—Asthenia—Sorafenib—kidney cancer	8.51e-05	0.000939	CcSEcCtD
Lidocaine—Hypersensitivity—Sunitinib—kidney cancer	8.4e-05	0.000928	CcSEcCtD
Lidocaine—Vomiting—Erlotinib—kidney cancer	8.38e-05	0.000925	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Vincristine—kidney cancer	8.33e-05	0.00092	CcSEcCtD
Lidocaine—Rash—Erlotinib—kidney cancer	8.31e-05	0.000918	CcSEcCtD
Lidocaine—Dermatitis—Erlotinib—kidney cancer	8.3e-05	0.000917	CcSEcCtD
Lidocaine—Eye disorder—Capecitabine—kidney cancer	8.27e-05	0.000914	CcSEcCtD
Lidocaine—Headache—Erlotinib—kidney cancer	8.25e-05	0.000912	CcSEcCtD
Lidocaine—Tinnitus—Capecitabine—kidney cancer	8.25e-05	0.000911	CcSEcCtD
Lidocaine—Loss of consciousness—Paclitaxel—kidney cancer	8.25e-05	0.000911	CcSEcCtD
Lidocaine—Pain—Vincristine—kidney cancer	8.25e-05	0.000911	CcSEcCtD
Lidocaine—Diplopia—Doxorubicin—kidney cancer	8.25e-05	0.000911	CcSEcCtD
Lidocaine—Osteoarthritis—Doxorubicin—kidney cancer	8.25e-05	0.000911	CcSEcCtD
Lidocaine—Paraesthesia—Gemcitabine—kidney cancer	8.22e-05	0.000908	CcSEcCtD
Lidocaine—Cardiac disorder—Capecitabine—kidney cancer	8.21e-05	0.000907	CcSEcCtD
Lidocaine—Flushing—Capecitabine—kidney cancer	8.21e-05	0.000907	CcSEcCtD
Lidocaine—Asthenia—Sunitinib—kidney cancer	8.18e-05	0.000904	CcSEcCtD
Lidocaine—Dyspnoea—Gemcitabine—kidney cancer	8.16e-05	0.000901	CcSEcCtD
Lidocaine—Nausea—Vinblastine—kidney cancer	8.14e-05	0.000899	CcSEcCtD
Lidocaine—Somnolence—Gemcitabine—kidney cancer	8.14e-05	0.000899	CcSEcCtD
Lidocaine—Convulsion—Paclitaxel—kidney cancer	8.14e-05	0.000898	CcSEcCtD
Lidocaine—Nausea—Everolimus—kidney cancer	8.11e-05	0.000896	CcSEcCtD
Lidocaine—Hypertension—Paclitaxel—kidney cancer	8.11e-05	0.000895	CcSEcCtD
Lidocaine—Angiopathy—Capecitabine—kidney cancer	8.03e-05	0.000887	CcSEcCtD
Lidocaine—Immune system disorder—Capecitabine—kidney cancer	8e-05	0.000883	CcSEcCtD
Lidocaine—Chest pain—Paclitaxel—kidney cancer	7.99e-05	0.000883	CcSEcCtD
Lidocaine—Anxiety—Paclitaxel—kidney cancer	7.97e-05	0.00088	CcSEcCtD
Lidocaine—Hypersensitivity—Dactinomycin—kidney cancer	7.96e-05	0.000879	CcSEcCtD
Lidocaine—Chills—Capecitabine—kidney cancer	7.94e-05	0.000877	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Gemcitabine—kidney cancer	7.9e-05	0.000873	CcSEcCtD
Lidocaine—Cardiac arrest—Doxorubicin—kidney cancer	7.84e-05	0.000866	CcSEcCtD
Lidocaine—Dizziness—Sorafenib—kidney cancer	7.84e-05	0.000866	CcSEcCtD
Lidocaine—Pain—Gemcitabine—kidney cancer	7.83e-05	0.000864	CcSEcCtD
Lidocaine—Nausea—Erlotinib—kidney cancer	7.83e-05	0.000864	CcSEcCtD
Lidocaine—Asthenia—Dactinomycin—kidney cancer	7.75e-05	0.000856	CcSEcCtD
Lidocaine—Confusional state—Paclitaxel—kidney cancer	7.73e-05	0.000853	CcSEcCtD
Lidocaine—Erythema—Capecitabine—kidney cancer	7.71e-05	0.000851	CcSEcCtD
Lidocaine—Oedema—Paclitaxel—kidney cancer	7.66e-05	0.000846	CcSEcCtD
Lidocaine—Anaphylactic shock—Paclitaxel—kidney cancer	7.66e-05	0.000846	CcSEcCtD
Lidocaine—Dysgeusia—Capecitabine—kidney cancer	7.55e-05	0.000833	CcSEcCtD
Lidocaine—Dizziness—Sunitinib—kidney cancer	7.54e-05	0.000833	CcSEcCtD
Lidocaine—Feeling abnormal—Gemcitabine—kidney cancer	7.54e-05	0.000833	CcSEcCtD
Lidocaine—Shock—Paclitaxel—kidney cancer	7.54e-05	0.000833	CcSEcCtD
Lidocaine—Vomiting—Sorafenib—kidney cancer	7.54e-05	0.000832	CcSEcCtD
Lidocaine—Nervous system disorder—Paclitaxel—kidney cancer	7.52e-05	0.00083	CcSEcCtD
Lidocaine—Rash—Sorafenib—kidney cancer	7.47e-05	0.000826	CcSEcCtD
Lidocaine—Dermatitis—Sorafenib—kidney cancer	7.47e-05	0.000825	CcSEcCtD
Lidocaine—Back pain—Capecitabine—kidney cancer	7.45e-05	0.000823	CcSEcCtD
Lidocaine—Headache—Sorafenib—kidney cancer	7.43e-05	0.00082	CcSEcCtD
Lidocaine—Hyperhidrosis—Paclitaxel—kidney cancer	7.41e-05	0.000818	CcSEcCtD
Lidocaine—Vision blurred—Capecitabine—kidney cancer	7.26e-05	0.000802	CcSEcCtD
Lidocaine—Vomiting—Sunitinib—kidney cancer	7.25e-05	0.000801	CcSEcCtD
Lidocaine—Tremor—Capecitabine—kidney cancer	7.22e-05	0.000797	CcSEcCtD
Lidocaine—Rash—Sunitinib—kidney cancer	7.19e-05	0.000794	CcSEcCtD
Lidocaine—Dermatitis—Sunitinib—kidney cancer	7.19e-05	0.000794	CcSEcCtD
Lidocaine—Hypotension—Paclitaxel—kidney cancer	7.16e-05	0.000791	CcSEcCtD
Lidocaine—Headache—Sunitinib—kidney cancer	7.15e-05	0.000789	CcSEcCtD
Lidocaine—Asthma—Doxorubicin—kidney cancer	7.13e-05	0.000787	CcSEcCtD
Lidocaine—Dysphagia—Doxorubicin—kidney cancer	7.13e-05	0.000787	CcSEcCtD
Lidocaine—Hypersensitivity—Vincristine—kidney cancer	7.11e-05	0.000785	CcSEcCtD
Lidocaine—Nausea—Sorafenib—kidney cancer	7.04e-05	0.000778	CcSEcCtD
Lidocaine—Asthenia—Vincristine—kidney cancer	6.92e-05	0.000765	CcSEcCtD
Lidocaine—Paraesthesia—Paclitaxel—kidney cancer	6.88e-05	0.00076	CcSEcCtD
Lidocaine—Vomiting—Dactinomycin—kidney cancer	6.87e-05	0.000758	CcSEcCtD
Lidocaine—Dyspnoea—Paclitaxel—kidney cancer	6.83e-05	0.000755	CcSEcCtD
Lidocaine—Somnolence—Paclitaxel—kidney cancer	6.81e-05	0.000752	CcSEcCtD
Lidocaine—Rash—Dactinomycin—kidney cancer	6.81e-05	0.000752	CcSEcCtD
Lidocaine—Nausea—Sunitinib—kidney cancer	6.78e-05	0.000748	CcSEcCtD
Lidocaine—Loss of consciousness—Capecitabine—kidney cancer	6.77e-05	0.000748	CcSEcCtD
Lidocaine—Hypertension—Capecitabine—kidney cancer	6.65e-05	0.000735	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.62e-05	0.000731	CcSEcCtD
Lidocaine—Asthenia—Gemcitabine—kidney cancer	6.57e-05	0.000725	CcSEcCtD
Lidocaine—Chest pain—Capecitabine—kidney cancer	6.56e-05	0.000725	CcSEcCtD
Lidocaine—Pain—Paclitaxel—kidney cancer	6.55e-05	0.000724	CcSEcCtD
Lidocaine—Anxiety—Capecitabine—kidney cancer	6.54e-05	0.000722	CcSEcCtD
Lidocaine—Nausea—Dactinomycin—kidney cancer	6.41e-05	0.000708	CcSEcCtD
Lidocaine—Dizziness—Vincristine—kidney cancer	6.38e-05	0.000705	CcSEcCtD
Lidocaine—Drowsiness—Doxorubicin—kidney cancer	6.36e-05	0.000702	CcSEcCtD
Lidocaine—Confusional state—Capecitabine—kidney cancer	6.34e-05	0.0007	CcSEcCtD
Lidocaine—Feeling abnormal—Paclitaxel—kidney cancer	6.31e-05	0.000697	CcSEcCtD
Lidocaine—Oedema—Capecitabine—kidney cancer	6.29e-05	0.000695	CcSEcCtD
Lidocaine—Neuropathy peripheral—Doxorubicin—kidney cancer	6.23e-05	0.000688	CcSEcCtD
Lidocaine—Stomatitis—Doxorubicin—kidney cancer	6.2e-05	0.000684	CcSEcCtD
Lidocaine—Shock—Capecitabine—kidney cancer	6.19e-05	0.000683	CcSEcCtD
Lidocaine—Nervous system disorder—Capecitabine—kidney cancer	6.17e-05	0.000681	CcSEcCtD
Lidocaine—Vomiting—Vincristine—kidney cancer	6.13e-05	0.000678	CcSEcCtD
Lidocaine—Urticaria—Paclitaxel—kidney cancer	6.09e-05	0.000672	CcSEcCtD
Lidocaine—Rash—Vincristine—kidney cancer	6.08e-05	0.000672	CcSEcCtD
Lidocaine—Hyperhidrosis—Capecitabine—kidney cancer	6.08e-05	0.000671	CcSEcCtD
Lidocaine—Dermatitis—Vincristine—kidney cancer	6.08e-05	0.000671	CcSEcCtD
Lidocaine—Headache—Vincristine—kidney cancer	6.04e-05	0.000668	CcSEcCtD
Lidocaine—Hypotension—Capecitabine—kidney cancer	5.88e-05	0.000649	CcSEcCtD
Lidocaine—Vomiting—Gemcitabine—kidney cancer	5.82e-05	0.000643	CcSEcCtD
Lidocaine—Bradycardia—Doxorubicin—kidney cancer	5.81e-05	0.000642	CcSEcCtD
Lidocaine—Rash—Gemcitabine—kidney cancer	5.77e-05	0.000637	CcSEcCtD
Lidocaine—Dermatitis—Gemcitabine—kidney cancer	5.77e-05	0.000637	CcSEcCtD
Lidocaine—Haemoglobin—Doxorubicin—kidney cancer	5.73e-05	0.000633	CcSEcCtD
Lidocaine—Headache—Gemcitabine—kidney cancer	5.73e-05	0.000633	CcSEcCtD
Lidocaine—Nausea—Vincristine—kidney cancer	5.73e-05	0.000633	CcSEcCtD
Lidocaine—Rhinitis—Doxorubicin—kidney cancer	5.72e-05	0.000632	CcSEcCtD
Lidocaine—Haemorrhage—Doxorubicin—kidney cancer	5.71e-05	0.00063	CcSEcCtD
Lidocaine—Hypoaesthesia—Doxorubicin—kidney cancer	5.68e-05	0.000627	CcSEcCtD
Lidocaine—Paraesthesia—Capecitabine—kidney cancer	5.65e-05	0.000624	CcSEcCtD
Lidocaine—Hypersensitivity—Paclitaxel—kidney cancer	5.65e-05	0.000624	CcSEcCtD
Lidocaine—Dyspnoea—Capecitabine—kidney cancer	5.61e-05	0.000619	CcSEcCtD
Lidocaine—Visual impairment—Doxorubicin—kidney cancer	5.5e-05	0.000607	CcSEcCtD
Lidocaine—Asthenia—Paclitaxel—kidney cancer	5.5e-05	0.000607	CcSEcCtD
Lidocaine—Nausea—Gemcitabine—kidney cancer	5.44e-05	0.0006	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Capecitabine—kidney cancer	5.43e-05	0.0006	CcSEcCtD
Lidocaine—Pain—Capecitabine—kidney cancer	5.38e-05	0.000594	CcSEcCtD
Lidocaine—Eye disorder—Doxorubicin—kidney cancer	5.33e-05	0.000589	CcSEcCtD
Lidocaine—Tinnitus—Doxorubicin—kidney cancer	5.32e-05	0.000588	CcSEcCtD
Lidocaine—Cardiac disorder—Doxorubicin—kidney cancer	5.3e-05	0.000585	CcSEcCtD
Lidocaine—Flushing—Doxorubicin—kidney cancer	5.3e-05	0.000585	CcSEcCtD
Lidocaine—Feeling abnormal—Capecitabine—kidney cancer	5.18e-05	0.000572	CcSEcCtD
Lidocaine—Angiopathy—Doxorubicin—kidney cancer	5.18e-05	0.000572	CcSEcCtD
Lidocaine—Immune system disorder—Doxorubicin—kidney cancer	5.15e-05	0.000569	CcSEcCtD
Lidocaine—Chills—Doxorubicin—kidney cancer	5.12e-05	0.000565	CcSEcCtD
Lidocaine—Dizziness—Paclitaxel—kidney cancer	5.07e-05	0.00056	CcSEcCtD
Lidocaine—Urticaria—Capecitabine—kidney cancer	5e-05	0.000552	CcSEcCtD
Lidocaine—Erythema—Doxorubicin—kidney cancer	4.97e-05	0.000549	CcSEcCtD
Lidocaine—Tension—Doxorubicin—kidney cancer	4.87e-05	0.000538	CcSEcCtD
Lidocaine—Vomiting—Paclitaxel—kidney cancer	4.87e-05	0.000538	CcSEcCtD
Lidocaine—Dysgeusia—Doxorubicin—kidney cancer	4.86e-05	0.000537	CcSEcCtD
Lidocaine—Rash—Paclitaxel—kidney cancer	4.83e-05	0.000534	CcSEcCtD
Lidocaine—Dermatitis—Paclitaxel—kidney cancer	4.83e-05	0.000533	CcSEcCtD
Lidocaine—Nervousness—Doxorubicin—kidney cancer	4.82e-05	0.000533	CcSEcCtD
Lidocaine—Back pain—Doxorubicin—kidney cancer	4.8e-05	0.000531	CcSEcCtD
Lidocaine—Headache—Paclitaxel—kidney cancer	4.8e-05	0.00053	CcSEcCtD
Lidocaine—Vision blurred—Doxorubicin—kidney cancer	4.68e-05	0.000517	CcSEcCtD
Lidocaine—Hypersensitivity—Capecitabine—kidney cancer	4.63e-05	0.000512	CcSEcCtD
Lidocaine—Agitation—Doxorubicin—kidney cancer	4.56e-05	0.000504	CcSEcCtD
Lidocaine—Nausea—Paclitaxel—kidney cancer	4.55e-05	0.000503	CcSEcCtD
Lidocaine—Asthenia—Capecitabine—kidney cancer	4.51e-05	0.000498	CcSEcCtD
Lidocaine—Loss of consciousness—Doxorubicin—kidney cancer	4.37e-05	0.000482	CcSEcCtD
Lidocaine—Convulsion—Doxorubicin—kidney cancer	4.3e-05	0.000475	CcSEcCtD
Lidocaine—Hypertension—Doxorubicin—kidney cancer	4.29e-05	0.000474	CcSEcCtD
Lidocaine—Chest pain—Doxorubicin—kidney cancer	4.23e-05	0.000467	CcSEcCtD
Lidocaine—Anxiety—Doxorubicin—kidney cancer	4.21e-05	0.000465	CcSEcCtD
Lidocaine—Dizziness—Capecitabine—kidney cancer	4.16e-05	0.000459	CcSEcCtD
Lidocaine—Confusional state—Doxorubicin—kidney cancer	4.09e-05	0.000451	CcSEcCtD
Lidocaine—Oedema—Doxorubicin—kidney cancer	4.05e-05	0.000448	CcSEcCtD
Lidocaine—Anaphylactic shock—Doxorubicin—kidney cancer	4.05e-05	0.000448	CcSEcCtD
Lidocaine—Vomiting—Capecitabine—kidney cancer	4e-05	0.000442	CcSEcCtD
Lidocaine—Shock—Doxorubicin—kidney cancer	3.99e-05	0.00044	CcSEcCtD
Lidocaine—Nervous system disorder—Doxorubicin—kidney cancer	3.98e-05	0.000439	CcSEcCtD
Lidocaine—Rash—Capecitabine—kidney cancer	3.97e-05	0.000438	CcSEcCtD
Lidocaine—Dermatitis—Capecitabine—kidney cancer	3.96e-05	0.000438	CcSEcCtD
Lidocaine—Headache—Capecitabine—kidney cancer	3.94e-05	0.000435	CcSEcCtD
Lidocaine—Hyperhidrosis—Doxorubicin—kidney cancer	3.92e-05	0.000433	CcSEcCtD
Lidocaine—Hypotension—Doxorubicin—kidney cancer	3.79e-05	0.000418	CcSEcCtD
Lidocaine—Nausea—Capecitabine—kidney cancer	3.74e-05	0.000413	CcSEcCtD
Lidocaine—Paraesthesia—Doxorubicin—kidney cancer	3.64e-05	0.000402	CcSEcCtD
Lidocaine—Dyspnoea—Doxorubicin—kidney cancer	3.61e-05	0.000399	CcSEcCtD
Lidocaine—Somnolence—Doxorubicin—kidney cancer	3.6e-05	0.000398	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.5e-05	0.000387	CcSEcCtD
Lidocaine—Pain—Doxorubicin—kidney cancer	3.47e-05	0.000383	CcSEcCtD
Lidocaine—Feeling abnormal—Doxorubicin—kidney cancer	3.34e-05	0.000369	CcSEcCtD
Lidocaine—Urticaria—Doxorubicin—kidney cancer	3.22e-05	0.000356	CcSEcCtD
Lidocaine—Hypersensitivity—Doxorubicin—kidney cancer	2.99e-05	0.00033	CcSEcCtD
Lidocaine—Asthenia—Doxorubicin—kidney cancer	2.91e-05	0.000321	CcSEcCtD
Lidocaine—Dizziness—Doxorubicin—kidney cancer	2.68e-05	0.000296	CcSEcCtD
Lidocaine—Vomiting—Doxorubicin—kidney cancer	2.58e-05	0.000285	CcSEcCtD
Lidocaine—Rash—Doxorubicin—kidney cancer	2.56e-05	0.000282	CcSEcCtD
Lidocaine—Dermatitis—Doxorubicin—kidney cancer	2.55e-05	0.000282	CcSEcCtD
Lidocaine—Headache—Doxorubicin—kidney cancer	2.54e-05	0.00028	CcSEcCtD
Lidocaine—Nausea—Doxorubicin—kidney cancer	2.41e-05	0.000266	CcSEcCtD
Lidocaine—CYP3A5—Metabolism—SCARB1—kidney cancer	4.87e-06	7.06e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PSMD7—kidney cancer	4.84e-06	7.01e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS1—kidney cancer	4.82e-06	6.99e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—POMC—kidney cancer	4.82e-06	6.99e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—FH—kidney cancer	4.79e-06	6.94e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—APRT—kidney cancer	4.79e-06	6.94e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PSMD7—kidney cancer	4.73e-06	6.86e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KIT—kidney cancer	4.71e-06	6.82e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ABCB1—kidney cancer	4.67e-06	6.77e-05	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—KRAS—kidney cancer	4.65e-06	6.74e-05	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.61e-06	6.69e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—BCHE—kidney cancer	4.59e-06	6.65e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CRABP1—kidney cancer	4.58e-06	6.64e-05	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—MAPK3—kidney cancer	4.57e-06	6.63e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GSTM1—kidney cancer	4.53e-06	6.57e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—SLC5A5—kidney cancer	4.53e-06	6.57e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GSTP1—kidney cancer	4.52e-06	6.56e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.51e-06	6.53e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GPC3—kidney cancer	4.5e-06	6.53e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—BCHE—kidney cancer	4.48e-06	6.5e-05	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.46e-06	6.47e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GSTT1—kidney cancer	4.46e-06	6.46e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ACHE—kidney cancer	4.46e-06	6.46e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—SLC5A5—kidney cancer	4.43e-06	6.42e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CA2—kidney cancer	4.38e-06	6.35e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—SLC2A1—kidney cancer	4.38e-06	6.34e-05	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—MAPK1—kidney cancer	4.35e-06	6.31e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—KIT—kidney cancer	4.34e-06	6.3e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—APC—kidney cancer	4.34e-06	6.3e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IGF2—kidney cancer	4.34e-06	6.29e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDH1—kidney cancer	4.33e-06	6.28e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN2B—kidney cancer	4.32e-06	6.26e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CRABP1—kidney cancer	4.32e-06	6.26e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CA9—kidney cancer	4.3e-06	6.24e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CYP1A1—kidney cancer	4.3e-06	6.23e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ABCB1—kidney cancer	4.28e-06	6.21e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CRABP1—kidney cancer	4.28e-06	6.2e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—SLC2A1—kidney cancer	4.28e-06	6.2e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALAD—kidney cancer	4.27e-06	6.19e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ITPR2—kidney cancer	4.26e-06	6.17e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—SCARB1—kidney cancer	4.22e-06	6.12e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.2e-06	6.09e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IGF1R—kidney cancer	4.2e-06	6.08e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS1—kidney cancer	4.18e-06	6.06e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	4.17e-06	6.04e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GSTM1—kidney cancer	4.16e-06	6.03e-05	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—KRAS—kidney cancer	4.11e-06	5.96e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PSMD7—kidney cancer	4.1e-06	5.94e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—BRAF—kidney cancer	4.08e-06	5.92e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	4.07e-06	5.9e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—RAF1—kidney cancer	4.04e-06	5.86e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ITPR2—kidney cancer	4.01e-06	5.82e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ITPR2—kidney cancer	3.98e-06	5.77e-05	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—KRAS—kidney cancer	3.94e-06	5.72e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CYP1A1—kidney cancer	3.94e-06	5.71e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.9e-06	5.66e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PGK1—kidney cancer	3.9e-06	5.66e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ACHE—kidney cancer	3.88e-06	5.63e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTT1—kidney cancer	3.88e-06	5.63e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—BCHE—kidney cancer	3.88e-06	5.63e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PTGS2—kidney cancer	3.85e-06	5.58e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—SLC5A5—kidney cancer	3.84e-06	5.56e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—LDHB—kidney cancer	3.83e-06	5.55e-05	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—PIK3CA—kidney cancer	3.77e-06	5.47e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.7e-06	5.37e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—RAF1—kidney cancer	3.69e-06	5.36e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—RELA—kidney cancer	3.68e-06	5.33e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—SCARB1—kidney cancer	3.68e-06	5.33e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.67e-06	5.32e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTT1—kidney cancer	3.66e-06	5.31e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ACHE—kidney cancer	3.66e-06	5.31e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CRABP1—kidney cancer	3.66e-06	5.3e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ERBB2—kidney cancer	3.65e-06	5.3e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GSTP1—kidney cancer	3.65e-06	5.29e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS1—kidney cancer	3.64e-06	5.28e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTT1—kidney cancer	3.63e-06	5.26e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ACHE—kidney cancer	3.63e-06	5.26e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL2—kidney cancer	3.62e-06	5.26e-05	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—PIK3CA—kidney cancer	3.62e-06	5.25e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MTOR—kidney cancer	3.61e-06	5.23e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD4—kidney cancer	3.6e-06	5.22e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.59e-06	5.21e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PSMD7—kidney cancer	3.57e-06	5.17e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GSTP1—kidney cancer	3.57e-06	5.17e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—SCARB1—kidney cancer	3.46e-06	5.02e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ABCB1—kidney cancer	3.45e-06	5.01e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HIF1A—kidney cancer	3.45e-06	5.01e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TSC2—kidney cancer	3.45e-06	5e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—SCARB1—kidney cancer	3.43e-06	4.98e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS1—kidney cancer	3.43e-06	4.97e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—RAF1—kidney cancer	3.41e-06	4.94e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ITPR2—kidney cancer	3.4e-06	4.93e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS1—kidney cancer	3.4e-06	4.93e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDKN1B—kidney cancer	3.38e-06	4.91e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—BCHE—kidney cancer	3.38e-06	4.9e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ABCB1—kidney cancer	3.38e-06	4.9e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—ERBB2—kidney cancer	3.37e-06	4.89e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PSMD7—kidney cancer	3.36e-06	4.88e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GSTM1—kidney cancer	3.35e-06	4.86e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PTEN—kidney cancer	3.35e-06	4.86e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—SLC5A5—kidney cancer	3.34e-06	4.84e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PSMD7—kidney cancer	3.33e-06	4.83e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MTOR—kidney cancer	3.33e-06	4.83e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—CD4—kidney cancer	3.32e-06	4.82e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CA9—kidney cancer	3.32e-06	4.81e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL2—kidney cancer	3.31e-06	4.8e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KDR—kidney cancer	3.3e-06	4.79e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTGS2—kidney cancer	3.3e-06	4.78e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GSTM1—kidney cancer	3.28e-06	4.75e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—SLC2A1—kidney cancer	3.23e-06	4.68e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—JUN—kidney cancer	3.22e-06	4.67e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—POMC—kidney cancer	3.21e-06	4.65e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CTNNB1—kidney cancer	3.2e-06	4.64e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—BCHE—kidney cancer	3.19e-06	4.62e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CYP1A1—kidney cancer	3.18e-06	4.61e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—BCHE—kidney cancer	3.16e-06	4.58e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—SLC5A5—kidney cancer	3.15e-06	4.57e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.13e-06	4.54e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.13e-06	4.54e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—CDKN1B—kidney cancer	3.12e-06	4.53e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—SLC5A5—kidney cancer	3.12e-06	4.53e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PTEN—kidney cancer	3.12e-06	4.52e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CYP1A1—kidney cancer	3.11e-06	4.51e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTT1—kidney cancer	3.1e-06	4.49e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ACHE—kidney cancer	3.1e-06	4.49e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GSTP1—kidney cancer	3.09e-06	4.48e-05	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.08e-06	4.46e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—APC—kidney cancer	3.04e-06	4.41e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KIT—kidney cancer	3.04e-06	4.41e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—SLC2A1—kidney cancer	3.04e-06	4.41e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—SLC2A1—kidney cancer	3.01e-06	4.37e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—CTNNB1—kidney cancer	2.95e-06	4.28e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—POMC—kidney cancer	2.94e-06	4.26e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SCARB1—kidney cancer	2.93e-06	4.25e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.93e-06	4.24e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ABCB1—kidney cancer	2.92e-06	4.24e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—MAPK3—kidney cancer	2.91e-06	4.22e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS1—kidney cancer	2.9e-06	4.21e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—POMC—kidney cancer	2.9e-06	4.2e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTEN—kidney cancer	2.88e-06	4.17e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—BRAF—kidney cancer	2.86e-06	4.15e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PSMD7—kidney cancer	2.85e-06	4.13e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GSTM1—kidney cancer	2.84e-06	4.12e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CRABP1—kidney cancer	2.82e-06	4.09e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—MAPK1—kidney cancer	2.77e-06	4.02e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—BCHE—kidney cancer	2.7e-06	3.92e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTP1—kidney cancer	2.69e-06	3.9e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.69e-06	3.9e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SLC5A5—kidney cancer	2.67e-06	3.87e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MAPK3—kidney cancer	2.66e-06	3.86e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ITPR2—kidney cancer	2.62e-06	3.8e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—KRAS—kidney cancer	2.62e-06	3.8e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SLC2A1—kidney cancer	2.58e-06	3.74e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS2—kidney cancer	2.56e-06	3.71e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.55e-06	3.7e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTP1—kidney cancer	2.54e-06	3.68e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MAPK1—kidney cancer	2.53e-06	3.67e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTP1—kidney cancer	2.51e-06	3.65e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.5e-06	3.62e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTM1—kidney cancer	2.47e-06	3.59e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MAPK3—kidney cancer	2.46e-06	3.56e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PIK3CA—kidney cancer	2.41e-06	3.49e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ABCB1—kidney cancer	2.4e-06	3.48e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KRAS—kidney cancer	2.39e-06	3.47e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTT1—kidney cancer	2.39e-06	3.47e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ACHE—kidney cancer	2.39e-06	3.47e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MYC—kidney cancer	2.39e-06	3.47e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RAF1—kidney cancer	2.39e-06	3.46e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ABCB1—kidney cancer	2.38e-06	3.45e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RELA—kidney cancer	2.38e-06	3.45e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—POMC—kidney cancer	2.37e-06	3.44e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PIK3CA—kidney cancer	2.37e-06	3.43e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ERBB2—kidney cancer	2.36e-06	3.43e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP1A1—kidney cancer	2.34e-06	3.4e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS2—kidney cancer	2.34e-06	3.4e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MAPK1—kidney cancer	2.34e-06	3.39e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MTOR—kidney cancer	2.33e-06	3.38e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTM1—kidney cancer	2.33e-06	3.38e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—POMC—kidney cancer	2.32e-06	3.36e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTM1—kidney cancer	2.31e-06	3.35e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SCARB1—kidney cancer	2.26e-06	3.28e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS1—kidney cancer	2.24e-06	3.25e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTEN—kidney cancer	2.23e-06	3.23e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.21e-06	3.21e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.21e-06	3.2e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—KRAS—kidney cancer	2.21e-06	3.2e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PSMD7—kidney cancer	2.2e-06	3.19e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PIK3CA—kidney cancer	2.2e-06	3.19e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.19e-06	3.18e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN1B—kidney cancer	2.19e-06	3.17e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.18e-06	3.16e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTP1—kidney cancer	2.15e-06	3.12e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL2—kidney cancer	2.14e-06	3.1e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCND1—kidney cancer	2.09e-06	3.03e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—BCHE—kidney cancer	2.08e-06	3.02e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—JUN—kidney cancer	2.08e-06	3.02e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CTNNB1—kidney cancer	2.07e-06	3e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.06e-06	2.98e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTEN—kidney cancer	2.04e-06	2.96e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ABCB1—kidney cancer	2.03e-06	2.95e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—PIK3CA—kidney cancer	2.03e-06	2.94e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTEN—kidney cancer	2.01e-06	2.92e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—POMC—kidney cancer	2.01e-06	2.91e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.99e-06	2.88e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTM1—kidney cancer	1.97e-06	2.86e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS2—kidney cancer	1.89e-06	2.74e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.87e-06	2.71e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS2—kidney cancer	1.85e-06	2.68e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—kidney cancer	1.82e-06	2.64e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.8e-06	2.61e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—POMC—kidney cancer	1.75e-06	2.53e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAPK3—kidney cancer	1.72e-06	2.5e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MYC—kidney cancer	1.67e-06	2.43e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTP1—kidney cancer	1.66e-06	2.4e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTEN—kidney cancer	1.65e-06	2.39e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—POMC—kidney cancer	1.65e-06	2.39e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAPK1—kidney cancer	1.64e-06	2.37e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—POMC—kidney cancer	1.63e-06	2.37e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTEN—kidney cancer	1.61e-06	2.34e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS2—kidney cancer	1.6e-06	2.32e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CA—kidney cancer	1.57e-06	2.28e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ABCB1—kidney cancer	1.57e-06	2.28e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KRAS—kidney cancer	1.55e-06	2.24e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.54e-06	2.23e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTM1—kidney cancer	1.52e-06	2.21e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.44e-06	2.09e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CA—kidney cancer	1.44e-06	2.09e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CA—kidney cancer	1.42e-06	2.06e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTEN—kidney cancer	1.4e-06	2.02e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—POMC—kidney cancer	1.4e-06	2.02e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS2—kidney cancer	1.39e-06	2.02e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—kidney cancer	1.37e-06	1.99e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS2—kidney cancer	1.31e-06	1.91e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS2—kidney cancer	1.3e-06	1.89e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTEN—kidney cancer	1.22e-06	1.76e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.16e-06	1.69e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTEN—kidney cancer	1.15e-06	1.66e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.14e-06	1.65e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTEN—kidney cancer	1.14e-06	1.65e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS2—kidney cancer	1.11e-06	1.61e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—POMC—kidney cancer	1.08e-06	1.56e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CA—kidney cancer	9.85e-07	1.43e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTEN—kidney cancer	9.71e-07	1.41e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS2—kidney cancer	8.59e-07	1.25e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CA—kidney cancer	8.58e-07	1.24e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CA—kidney cancer	8.08e-07	1.17e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CA—kidney cancer	8.01e-07	1.16e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTEN—kidney cancer	7.49e-07	1.09e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CA—kidney cancer	6.85e-07	9.93e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CA—kidney cancer	5.29e-07	7.66e-06	CbGpPWpGaD
